Changes in outcomes over time in intermediate-risk patients treated for severe aortic stenosis.
Khalil N KhalilMarouane BoukhrisMalek BadreddineWalid Ben AliLouis-Mathieu StevensJean-Bernard MassonJeannot PotvinJean-François GobeilNicolas NoiseuxPaul KhairyJessica ForcilloPublished in: Journal of cardiac surgery (2020)
Data showed an improvement in morbidities/mortality for intermediate-risk patients treated with SAVR or TAVR. Increased funding allowed for a higher TAVR volume by increasing access to this technology. Also, the difference in complications could impact healthcare costs. By incorporating important metrics such as length-of-stay, readmission rates, and complications into decision-making, the Heart-Team can improve clinical outcomes, healthcare economics, and resource utilization.
Keyphrases
- aortic stenosis
- transcatheter aortic valve replacement
- healthcare
- aortic valve
- ejection fraction
- aortic valve replacement
- transcatheter aortic valve implantation
- left ventricular
- risk factors
- decision making
- coronary artery disease
- heart failure
- atrial fibrillation
- cardiovascular events
- adipose tissue
- type diabetes
- machine learning
- big data
- skeletal muscle
- insulin resistance